Quarter 3 2002 Results Dr John Climax CEO

  • Slides: 14
Download presentation
Quarter 3, 2002 Results Dr John Climax, CEO Mr Peter Gray, COO Mr Sean

Quarter 3, 2002 Results Dr John Climax, CEO Mr Peter Gray, COO Mr Sean Leech, CFO Dr Ronan Lambe, Chairman http: //www. iconclinical. com

Forward Looking Statements Certain statements contained herein including, without limitation, statements containing the words

Forward Looking Statements Certain statements contained herein including, without limitation, statements containing the words “believes, ” “anticipates, ” “intends, ” “expects” and words of similar import, constitute forward-looking statements concerning the Company's operations, performance, financial condition and prospects. Because such statements involve known and unknown risks and uncertainties, actual results may differ materially from those expressed or implied by such forward-looking statements. Given these uncertainties, prospective investors are cautioned not to place undue reliance on such forward-looking statements. The Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. Slide 1

Net Revenue Growth – Regional Split $113. 6 m 34% Europe/Ro. W $84. 6

Net Revenue Growth – Regional Split $113. 6 m 34% Europe/Ro. W $84. 6 m USA 33% $29. 7 m 34% 33% Slide 2 $39. 6 m 49% 29%

% of Net Revenue – Quarter 3, 2002 Quarter 2001 Year to date S,

% of Net Revenue – Quarter 3, 2002 Quarter 2001 Year to date S, G&A/D&A Slide 3 Direct Costs Income from Operations

$m Quarterly Revenue and Operating Income Q 3 2001 Slide 4 Q 4 2001

$m Quarterly Revenue and Operating Income Q 3 2001 Slide 4 Q 4 2001 Q 1 2002 Q 2 2002 Q 3 2002

Quarterly Operating Margins Q 2 2001 Slide 5 Q 3 2001 Q 4 2001

Quarterly Operating Margins Q 2 2001 Slide 5 Q 3 2001 Q 4 2001 Q 1 2002 Q 2 2002 Q 3 2002

Quarterly Effective Tax Rates Q 2 2001 Slide 6 Q 3 2001 Q 4

Quarterly Effective Tax Rates Q 2 2001 Slide 6 Q 3 2001 Q 4 2001 Q 1 2002 Q 2 2002 Q 3 2002

$m Quarterly Earnings per Share and Net Income Q 3 2001 Slide 7 Q

$m Quarterly Earnings per Share and Net Income Q 3 2001 Slide 7 Q 4 2001 Q 1 2002 Q 2 2002 Q 3 2002

Balance Sheet Feb 28, 2002 Slide 8 May 31, 2001 Cash Debt Net Cash

Balance Sheet Feb 28, 2002 Slide 8 May 31, 2001 Cash Debt Net Cash $ 55. 2 m $(10. 2)m $ 45. 0 m $ 47. 1 m $ (11. 2)m $ 35. 9 m Accounts Receivable Unbilled Revenue Payments on Account Total Debtors $ 32. 7 m $ 25. 0 m $(18. 3)m $ 39. 4 m $20. 5 m $(11. 1)m $38. 8 m DSOs 70 Days 93 Days

Net New Business Wins (US$) Q 2 2001 Slide 9 Q 3 2001 Q

Net New Business Wins (US$) Q 2 2001 Slide 9 Q 3 2001 Q 4 2001 Q 1 2002 Q 2 2002 Q 3 2002

Backlog; - To be earned in the next 12 months; - and as %

Backlog; - To be earned in the next 12 months; - and as % of Market Forecasts 77% 80%+ 76% Q 1 2002 Q 2 2002 80% 82%+ 78% 79% 76% Q 4 2000 Slide 10 Q 1 2001 Q 2 2001 Q 3 2001 Q 4 2001 Q 3 2002

Quarter 3, 2002 Results Dr John Climax, CEO Mr Peter Gray, COO Mr Sean

Quarter 3, 2002 Results Dr John Climax, CEO Mr Peter Gray, COO Mr Sean Leech, CFO Dr Ronan Lambe, Chairman Slide 11 http: //www. iconclinical. com

Questions & Answers Dr John Climax, CEO Mr Peter Gray, COO Mr Sean Leech,

Questions & Answers Dr John Climax, CEO Mr Peter Gray, COO Mr Sean Leech, CFO Dr Ronan Lambe, Chairman Slide 12 http: //www. iconclinical. com

Summary n 33% increase in Net Revenue in quarter n 26% increase in EPS

Summary n 33% increase in Net Revenue in quarter n 26% increase in EPS in quarter n Strong RFP flows n Over $45 m Net Awards in quarter n 77% of next 12 months revenues in backlog Slide 13 http: //www. iconclinical. com